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Abstract: pH-sensitive gated mesoporous silica nanoparticles have been synthesized. Increased 
extracellular pH and internalization into living yeast cells triggered molecular gate aperture 
and cargo release. Proper performance of the system was demonstrated with nanodevices loaded 
with fluorescein or with the antifungal agent tebuconazole. Interestingly, nanodevices loaded 
with tebuconazole significantly enhanced tebuconazole cytotoxicity. As alterations of acidic 
external pH are a key parameter in the onset of fungal vaginitis, this nanodevice could improve 
the treatment for vaginal mycoses.
Keywords: capped mesoporous nanoparticles, intracellular release, pH-responsive  nanoparticles, 
Saccharomyces cerevisiae, tebuconazole loading
Introduction
Vaginitis is an inflammation of the vagina, often associated with irritation or infection 
of the vulva. Vulvovaginitis is very common and affects women of all ages. Indeed, 
75% of all women will suffer from this condition at least once throughout their lives.1 
If left untreated, it can lead to further complications, especially for pregnant women. 
Infectious vaginitis can account for more than 90% of all vulvovaginitis cases. It is 
caused by either bacterial or, most frequently, Candida infections.2
Candida is among the normal organisms that are part of the commensal flora of the 
gut, mouth, and genital tract.3 These yeasts will multiply when their habitat becomes 
altered under particular conditions, such as immunosuppression, administration of 
antibiotics, pregnancy, the luteal phase of the menstrual cycle, diabetes mellitus, or oral 
contraceptive intake.3,4 As a consequence, Candida infection causes the elimination of 
beneficial micro-organisms from the endogenous vaginal flora (especially Döderlein’s 
bacillus), one of the natural mechanisms of defense. Metabolism of lactobacillus 
present in the genital tract generates lactic acid, which is principally responsible for 
maintaining a normal vaginal pH around 3.8–4.4. This acid environment hinders the 
growth of other pathogenic micro-organisms acting as a protecting barrier. If there 
is an increase in the pH to values around 5.5–6.8, an overgrowth of Candida occurs, 
thus causing the most common vulvovaginal infections.4
Management of vaginal candidiasis includes oral or topical antibiotics and/or 
antifungal creams or similar medications.4 Most of the available effective antifungal 
agents are based on polyenes (amphotericin B), triazoles (fluconazole, itraconazole), 
or echinocandins.1,5 Although both oral and topical treatments are equally effective, 
oral therapies are strongly associated with systemic side effects. Topical therapies 
are less frequently associated with adverse effects, which include irritation, itching, 
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burning, and development of yeast resistance to antifungal 
agents.5 Their better therapeutic profile, together with cost-
effectiveness, makes topical therapies the option of choice 
for management of vaginal candidiasis.
Although silver5,6 and silica nanoparticles7 have been used as 
antifungals against Candida spp., we believe that the use of gated 
mesoporous materials could be an interesting alternative as drug 
carriers in order to avoid the mentioned adverse effects.
The development of nanoscopic hybrid materials able to 
deliver cargo under a certain external trigger action has been 
considered a highly interesting area of research and has been 
extensively explored in the last few years.8,9 These nanode-
vices have been demonstrated to be an excellent approach for 
advanced controlled release research.9–17 Gated mesoporous 
supports are composed basically of two subunits, a suitable 
scaffolding, and certain entities anchored on the support sur-
face.18 The support is employed as a container in which certain 
chemical species could be stored, whereas the grafted molecules 
in the outer surface of the scaffold act as a molecular gate, con-
trolling the cargo release at will. The selection of both scaffold 
and anchored entities of the nanodevice has to be done carefully, 
given the required functionalities of the final system.
In this context, silica mesoporous supports are widely 
used as inorganic scaffolds, thanks to several favorable 
features, including homogeneous porosity, high chemical 
inertness, robustness, thermal stability, high loading capac-
ity, biocompatibility, and ease of functionalization through 
the well-known chemistry of alkoxysilanes.19–28 Although 
mesoporous silica supports have been used for the simple 
diffusion-controlled release of certain antibiotics29–31 and 
antifungals,4,32 similar studies using capped materials show-
ing zero release and able to deliver cargo only in the presence 
of fungi have not been described.
We aimed to design and test a new nanodevice for the 
intracellular controlled release of an antifungal in opportunistic 
fungi, such as Candida spp., reproducing the biological condi-
tions of the vagina ecosystem. When growing in the yeast form, 
Candida albicans is morphologically similar to  Saccharomyces 
cerevisiae,33 validating budding yeast as a model for fungal 
infections.34 Furthermore, S. cerevisiae itself can also cause 
vaginal yeast infections.35 We hypothesize that apart from the 
increase of the vaginal pH under certain conditions, nano-
particle internalization in budding yeast would trigger the 
opening of the nanodevice and the release of the entrapped 
antifungal molecule. This would be so because at pH ,5 the 
amine groups are protonated and the electrostatic repulsions 
between the organic moieties and the interaction with anions 
in the medium maintains the gate closed. At pH .5 the amine 
groups are less protonated, weakening the electrostatic interac-
tions and causing opening of the gate, which is followed by a 
massive outflow of the entrapped moieties.36,37
Material and methods
chemicals
The chemicals tetraethyl orthosilicate (TEOS) (98%), 
n-cetyltrimethylammonium bromide (CTAB) ($99%), 
sodium hydroxide ($98%), fluorescein (FL), tebuconazole, 
and 3-[2-(2-aminoethylamino)ethylamino]propyltrimethox-
ysilane (N3) were provided by Sigma-Aldrich (St Louis, MO, 
USA). The culture yeast was also provided by Sigma-Aldrich. 
Solvents were purchased from Scharlab, SA (Barcelona, 
Spain). All reagents were used as received.
General techniques
Powder X-ray diffraction (PXRD), thermogravimetry analysis 
(TGA), elemental analysis, transmission electron microscopy 
(TEM), and nitrogen adsorption–desorption techniques were 
employed to characterize the prepared materials. PXRD measure-
ments were performed on a Philips D8 Advance  Diffractometer 
using Cu Kα radiation. TGA was carried out on a TGA/SDTA 
851e Mettler-Toledo S.A.E. (Barcelona, Spain) balance using an 
oxidant atmosphere (air, 80 mL/minute) with a heating program 
consisting of a heating ramp of 10K per minute 393–1,273 K and 
an isothermal heating step at this temperature for 30 minutes. 
Elemental analysis was performed in a CE Instrument EA-1110 
CHN Elemental Analyzer. TEM images were obtained with a 
100 kV JEOL JEM-1010 microscope (JEOL, Tokyo, Japan). 
Nitrogen adsorption–desorption isotherms were recorded on 
a Micromeritics ASAP2010 (Bonsai Advanced Technologies 
SL., Madrid, Spain) automated sorption analyzer. The samples 
were degassed at 120°C in a vacuum overnight. The specific 
surface areas were calculated from the adsorption data in the 
low pressures range using the Brunauer–Emmett–Teller (BET) 
theory model.38 Pore size was determined following the Barrett–
Joyner–Halenda (BJH) method.39 Fluorescence spectroscopy 
was carried out on a Felix 32 Analysis Version 1.2 (Build 56) 
(Microbeam SA, Barcelona, Spain). Yeast cultures were inocu-
lated in a Telstar AH100 (Madrid, Spain) cell culture hood, grown 
at 30°C using a microbiology culture shaker (Kühner 25 mm; 
Adolf Kühner AG, Basel, Switzerland), and monitored under 
microscopy with a Nikon Eclipse E500 (Nikon Instruments 
Europe B.V. Amsterdam, the Netherlands).
Synthesis of the nanoparticles
Synthesis of the silica support
The MCM-41 (mobil composition of matter-41) mesoporous 
nanoparticles were synthesized by the following procedure: 
CTAB (1.00 g, 2.74 mmol) was first dissolved in deionized water 
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(480 mL). After that, NaOH (3.5 mL, 2.00 M) in deionized water 
was added to the CTAB solution. Next, the solution temperature 
was adjusted to 80°C. TEOS (5.00 mL, 2.57×10-2 mol) was 
then added dropwise to the surfactant solution. The mixture 
was stirred for 2 hours to yield a white precipitate. Finally, the 
solid product was centrifuged, washed with deionized water and 
ethanol, and dried at 60°C (MCM-41 as synthesized). To prepare 
the final porous material (MCM-41), the as synthesized solid 
was calcined at 550°C using an oxidant atmosphere for 5 hours 
in order to remove the template phase, (CTAB), thus eliminating 
any residual CTAB that might negatively affect cell viability.
Synthesis of MCM-41 loaded with tebuconazole 
(S1-Teb)
In a typical synthesis, template-free MCM-41 (150 mg) was 
suspended in a solution of tebuconazole (16 mg in 7 mL of 
CH
2
Cl
2
 for a ratio of 0.35 mmol of tebuconazole/g MCM-41) 
and the subsequent suspension stirred for 24 hours at room tem-
perature. Then, an excess of N3 (0.4 mL, 1.4 mmol) was added 
and the mixture was stirred for 5.5 hours at room temperature. 
The obtained solid was filtered, washed with CH
2
Cl
2
 (4 mL), 
and dried under vacuum. Then, this solid was suspended in 
water at pH 2 (25 mL) in the presence of sulfate for 10 minutes, 
in order to maintain the gate closed due to amine protonation. 
The final solid nanodevice loaded with tebuconazole was dried 
under a vacuum and stored at 37°C for 24 hours.
Yeast preparation for S1-Teb uptake  
and cell viability assay
Following a similar yeast treatment as for solid nanodevices 
loaded with FL (S1-FL) assays, BY4741 cells were cultured 
in yeast peptone dextrose (YPD) medium overnight at 28°C 
with continuous agitation at a density of 108 cells/mL. Nine 
milliliters of this suspension was centrifuged for 1 minute at 
3,000 rpm and the precipitate was resuspended with 900 µL 
of simulated vaginal fluid (SVF). Two more washes were done 
by adding 900 µL of SVF to the previous pellet, and 100 µL of 
the final cell suspension was introduced in different Eppendorf 
vials. The SVF was prepared as described by Marques et al.40 
SVF composition in g/L was as follows: sodium chloride 
3.51, potassium hydroxide 1.40, calcium hydroxide 0.222, 
bovine serum albumin 0.018, lactic acid 2.00, acetic acid 
1.00, glycerol 0.16, urea 0.40, and glucose 5.00. Then, SVF 
was adjusted to pH 4.2 with HCl and saved using a sterilized 
vacuum filtration system.
Results and discussion
Firstly, a material (S1-FL) consisting of mesoporous nano-
particle (MSN) support (MCM-41) loaded with a dye and 
capped with an organic molecular entity was designed. The 
starting nanoparticulated MCM-41 mesoporous solid was 
synthesized following well-known procedures using CTAB as 
a template and TEOS as a hydrolytic inorganic precursor.19–24 
Then, MCM-41 solid was obtained after calcinations and 
loaded with the FL dye. As a molecular gate, the organic 
entity N3, which contains three amine groups per molecule, 
was selected.
This solid was synthesized, characterized, and tested 
in vitro (see Supplementary materials for synthesis, char-
acterization, and in vitro results of S1-FL). For the in vitro 
assays, S. cerevisiae cells were incubated in a medium at 
pH 3.7 with S1-FL at different concentrations (0.65, 1.25, 
2.5, and 5 mg/mL) at 40°C for 6 hours. After the heat shock 
treatment, cells were seeded in plates and incubated for 
72 hours. No cell viability differences were found among S. 
cerevisiae cells incubated in regular conditions and the ones 
incubated at 40°C (data not shown). Moreover, 72 hours is 
the average time required for yeast colonies to grow up to 
a size of 1–2 mm, where they can be visually quantitated. 
Cellular uptake was monitored by fluorescence microscopy 
(see Supplementary materials).
The cellular uptake of nanoparticles was followed by FL-
associated fluorescence (green). The cells incubated at pH 
3.7 and treated with S1-FL showed a normal phenotype when 
compared with control cells. Besides, an FL-associated fluo-
rescence signal was observed, thus proving the internalization 
and aperture of nanoparticles. In order to rule out any pos-
sible toxic effect of nanoparticles under the test conditions, 
cell viability was monitored throughout the experiments by 
clonogenic assays. No cell toxicity associated with S1-FL 
was observed (see Supplementary materials).
After these satisfactory results with S1-FL nanoparticles, 
we next designed, prepared, characterized, and tested a new 
material, S1-Teb, as a possible therapeutic antifungal carrier. 
This nanoparticle design and action mechanism is shown in 
Figure 1.
Under normal vaginal conditions (Figure 1A), pH remains 
between 3.8 and 4.4. As a consequence, the molecular gate 
in S1-Teb material is closed, and no tebuconazole release is 
produced. Only a few nanoparticles could cross the vaginal 
epithelium with virtually no toxicity, because tebuconazole’s 
molecular target, encoded by the lanosterol 14-alpha-
demethylase (ERG11) gene,41 is not present in human cells. 
When a C. albicans infection occurs in the vaginal environ-
ment (Figure 1B), pH is increased (pH .5.5), thus opening 
the gate and releasing tebuconazole.
Moreover, some of the S1-Teb nanoparticles would be 
internalized in C. albicans (S. cerevisiae in our case), where 
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tebuconazole delivery should also occur. Increased lethality 
of C. albicans cells should be expected in this case.
Nanometric mesoporous MCM-41 phase (∼100 nm) was 
selected as inorganic support. MCM-41 nanoparticles were 
synthesized following the same procedures as for S1-FL19–24 
and obtained after calcination. Then, this calcined material 
was loaded in this case with tebuconazole, an antifungal drug 
from the triazoles family whose solubility and size proper-
ties resemble those of econazole nitrate.4 Then, the external 
surface of the nanoparticles was also functionalized with N3 
(see Materials and methods for experiment details).
The MCM-41 structure was confirmed by PXRD and 
TEM techniques (see Figure 2A and B), which presented the 
expected features of this type of mesoporous material.
The nitrogen adsorption–desorption isotherms of the 
prepared phase (see Figure 3A) show a typical Pearson 
type IV curve with a specific surface area of 998.4 m2g–1, 
calculated with the BET38 model. The absence of a hysteresis 
loop in this interval and the narrow BJH39 pore size distribu-
tion, with an average pore diameter of 2.45 nm, indicates 
the existence of uniform cylindrical mesopores with a pore 
volume of 0.76 cm3g–1.
A
3.8< pH <4.4
S1-Teb
pH increase
3.8< pH <4.4 pH >5.5
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Normal vaginal epithelium
MCM-41 nanoparticles
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N3: 3[2-(2-aminoethylamino)
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B
Figure 1 Schematic representation of the design and action mechanism of S1-Teb 
under usual vaginal conditions (A) and in the presence of Candida albicans (B) 
(Saccharomyces cerevisiae has been used in experimental assays as a model organism).
Abbreviation: MCM-41, mobil composition of matter-41; S1-Teb, MCM-41 loaded 
with tebuconazole.
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Figure 3 S1-Teb characterization results. (A) Nitrogen adsorption–desorption 
isotherms of MCM-41 calcined and S1-Teb. (B) Contents in mmol/g SiO2 for S1-Teb. 
Insets: Pore size distribution of MCM-41 calcined.
Abbreviations: MCM-41, mobil composition of matter-41; STP, standard tempera-
ture and pressure; S1-Teb, MCM-41 loaded with tebuconazole.
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Figure 2 S1-Teb characterization results. (A) Powder X-ray pattern of MCM-41 as 
made, MCM-41 calcined, and S1-Teb. (B) Transmission electron microscopy image 
of MCM-41 calcined and S1-Teb.
Abbreviations: McM-41, mobil composition of matter-41; S1-Teb, MCM-41 
loaded with tebuconazole.
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The prepared solid S1-Teb was also characterized using 
standard techniques. S1-Teb displays expected characteristics 
of the MCM-41 phase, as can be observed in the X-ray pattern 
(Figure 2A) and TEM image in Figure 2B. This suggests that 
loading and functionalization procedures did not modify the 
mesoporous structure of the starting material. Additionally, the 
nitrogen adsorption–desorption isotherm of S1-Teb was typi-
cal of gated and filled mesoporous systems, and a significant 
decrease in the nitrogen volume adsorbed was observed (0.04 
cm3g–1), and in surface area (46.3 m2g–1), when compared 
with the starting MCM-41 material (see Figure 3A). Finally, 
the organic content of the final S1-Teb solid was determined 
by thermogravimetric and elemental analysis. The amounts of 
tebuconazole and capping molecule N3 obtained in the final 
material were 0.064 and 2.43 mmol/g SiO
2
, respectively (see 
Figure 3B).
Yeast uptake and cell viability  
assay with S1-Teb
Different solutions of free tebuconazole and suspensions of 
solid S1-Teb with several concentrations (0–200 µg tebucon-
azole/mL) were prepared by adding dimethyl sulfoxide 2× and 
SVF at a final volume of 200 µL and 2% dimethyl sulfoxide 
concentration. The amount of free drug used in the study was 
the same as that contained in the capped solid S1-Teb, calcu-
lated by elemental analysis and thermogravimetry studies (see 
Supplementary materials). Then, 100 µL of the aforementioned 
solutions or solid suspensions were added to the different 
Eppendorf vials containing 100 µL of the yeast suspension 
(for yeast preparation treatment see  Supplementary materials). 
These final yeast suspensions containing different amounts of 
free tebuconazole or S1-Teb (0–100 µg tebuconazole/mL) were 
incubated for 6 hours at 37°C with no stirring. After the incuba-
tion period, approximately 300 cells were seeded in a YPD plate 
and incubated at 28°C for 72 hours. Finally, colony formation 
units (CFUs) were  quantified. The results of the experiments 
containing duplicates were repeated twice (see Figure 4).
Satisfactorily, as can be observed, when 100 µg/mL of 
antifungal is used for both formulations (free and S1-Teb), 
a very low cell growth value was obtained with the nano-
particles (around 10% CFUs were quantified), whereas most 
of the cells were grown (around 90% CFUs) with the free 
antifungal. Practically no significant cell death was achieved 
with the use of free drug, whereas close to 90% cell death 
was achieved with S1-Teb.
Conclusion
In summary, a study of the controlled release of different cargo 
molecules from a mesoporous silica-based material gated with 
a polyamine able to remain closed at an acidic pH, is described. 
For the capped solid loaded with FL (S1-FL), in vitro studies 
showed a selective delivery over 5.5 pH, whereas the molecular 
gate remains closed at an acidic pH 3.7. Intracellular cargo 
release and cell viability studies were carried out to analyze 
the behavior of the solid by employing S. cerevisiae, which 
is a micro-organism that survives in acidic environments, 
and perfectly suits the aperture mechanism of synthesized 
nanoparticles. Satisfactorily, S1-FL cell viability studies dem-
onstrated the nontoxicity of the material. Moreover, this solid 
perfectly internalized in yeast cells, producing the subsequent 
FL delivery due to the 5.5 pH, as the fluorescence microscopy 
images demonstrate (see Supplementary materials). In order 
to demonstrate the potential of this capped material in a 
therapeutic field as a possible antifungal carrier, other material 
(S1-Teb) consisting of silica mesoporous support containing 
an antifungal, tebuconazole, was prepared. Accordingly, a 
nine-fold increase in tebuconazole cytotoxicity was obtained 
by using S1-Teb nanoparticles, when compared with that of 
free antifungal. Therefore, the designed nanoformulation con-
siderably improves tebuconazole efficacy. The enhancement 
of tebuconazole action could potentially overcome the adverse 
side effects associated with topical therapies for vulvovaginal 
infection and significantly improve its cost-effectiveness.
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Supplementary materials
Synthesis of S1-FL
In a typical synthesis, template-free MCM-41 (mobil com-
position of matter-41) (100 mg) and fluorescein (FL) (16.8 
mg, 0.007 mmol) were suspended in methanol (40 mL) 
inside a round-bottomed flask in an inert atmosphere. The 
mixture was stirred for 24 hours at room temperature in order 
to achieve maximum loading in the pores of the MCM-41 
scaffolding. Then, an excess of 3-[2-(2-aminoethylamino)
ethylamino]propyltrimethoxysilane (N3) (0.2 mL, 0.7 mmol) 
was added and the final mixture was stirred for 5.5 hours at 
room temperature. Finally, the solid (nanodevice loaded with 
fluorescein [S1-FL]) was filtered and washed with methanol 
(40 mL). Once it was dried, the solid was suspended in water 
at pH 2 in the presence of sulfate (at this pH, the molecular 
gate is closed) in order to remove the dye remaining outside 
the pores. After 12 hours, the solid was filtered and dried at 
37°C for 24 hours.
S1-FL characterization
Synthesized material S1-FL was characterized by standard 
techniques. Figure S1A shows the powder X-ray diffraction 
(PXRD) patterns of solids MCM-41 as synthesized, MCM-41 
calcined, and S1-FL. The PXRD of the mesoporous MCM-41 
as synthesized material (curve [a]) showed four peaks, which 
are typical of a hexagonal ordered array, indexed as (100), 
(110), (200), and (210) Bragg reflexions. From the PXRD 
data, an a0 cell parameter of 2.27 Å was calculated. In curve 
(b) (the MCM-41 calcined sample), an important shift of the 
(100) to larger angles in PXRD and a broadening of the (110) 
and (200) reflections were clearly found and attributed to the 
condensation of the silanol groups in the calcination step. 
Figure S1 also depicts the PXRD pattern for solid S1-FL. 
For this material, reflections (110) and (200) were almost 
lost, probably due to diminished contrast as a result of the 
loading and functionalization process. Nevertheless, the clear 
presence in S1-FL of the d100 peak in the XRD patterns sup-
ports that pore loading, and the additional functionalization 
with the amine derivative did not modify the mesoporous 
structure of the starting MCM-41 scaffolding.
Preservation of the mesoporous structure in both the 
calcined MCM-41 material and the final functionalized solid 
S1-FL was also confirmed by means of the transmission 
electron microscopy images. In both solids, the characteristic 
channels of a mesoporous matrix were observed as alternate 
black and white lines. Figure S1B shows the morphology of 
the prepared mesoporous MCM-41 and S1-FL materials as 
spherical nanoparticles with a mean diameter of ∼100 nm.
In order to complement the information provided by the 
X-ray and the transmission electron microscopy analyses, 
porosimetry studies for the MCM-41 calcined material and 
the final S1-FL materials were carried out (Table S1). The 
nitrogen adsorption–desorption isotherms of the nanoparticu-
lated MCM-41 calcined material are shown in Figure S2A. 
A typical curve for these mesoporous solids, consisting of 
an adsorption step at an intermediate P/P
0
 value (0.1–0.3), 
is observed. The absence of a hysteresis loop in this interval 
and the narrow BJH pore distribution suggest the existence of 
uniform cylindrical mesopores (pore diameter of 3.09 nm and 
pore volume of 0.935 cm3 g–1 calculated by the BJH model 
on the adsorption branch of the isotherm). The application 
of the BET model resulted in a value of 1096 m2/g for the 
total  specific surface. For S1-FL, the nitrogen adsorption– 
desorption isotherm (Figure S2) presented the typical 
characteristics of a mesoporous system with partially filled 
mesopores. Therefore, lower nitrogen adsorbed volume (BJH 
mesopore volume =0.482 cm3 g–1) and surface area (424 m2/g) 
values were calculated. Despite the significant drop in 
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Figure S1 (A) The powder X-ray diffraction patterns of the solids (a) MCM-41 as 
synthesized, (b) calcined MCM-41, and (c) solid nanodevice loaded with fluorescein (S1-
FL) containing FL dye and 3-[2-(2-aminoethylamino)ethylamino]propyltrimethoxysilane. 
The transmission electron microscopy images of (B) the calcined MCM-41 sample and 
(C) S1-FL showing the typical porosity of the MCM-41 mesoporous matrix.
Abbreviations: MCM-41, mobil composition of matter-41; I/au, intensity/arbitrary units.
Table S1 BET specific surface values, pore volumes, and pore 
sizes calculated from the nitrogen adsorption–desorption 
isotherms for selected materials
 SBET  
(m2 g–1)
Pore volume  
(cm3 g–1)
Pore size 
(nm)
McM-41 1,097 0.94 3.09
s1-Fl 424 0.48 3.49
Abbreviations: S1-FL, nanodevice loaded with fluorescein; MCM-41, mobil 
composition of matter-41; BET, Brunauer–Emmett–Teller theory.
International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2604
Mas et al
pore volume, some features were still observed in the BJH 
 mesopore size distribution, such as a maximum at ∼1.8 nm 
(on the border between mesopores and micropores).
Having determined the structure of the nanoparticles 
synthesized, the amount of guest molecule and N3 on solid 
S1-FL was determined by thermogravimetric analysis. 
Table S2 offers the results obtained.
Release kinetics of S1-FL
In order to check the proper aperture mechanism of solid 
S1-FL, 10 mg was suspended in 25 mL of water containing 
sulfate anions at a final concentration of 0.01 M at different 
pH (3.7 and 5.5). Suspensions were stirred at room tem-
perature and, at a given time, aliquots were separated and 
filtered. The delivery of FL from the pore voids to the aqueous 
solution was monitored via its fluorescence emission band 
at 517 nm (λ
ex
=494 nm). Due to the influence of pH on the 
fluorescence of FL, all the taken aliquots were treated with 
the amount of NaOH required to increase their pH to 8.
The dye delivery at different pH is depicted in Figure S3. 
At the more acidic pH of 3.7, S1-FL was tightly capped 
and displayed no significant FL release. In contrast, at pH 
5.5, the cargo molecule was released. The interpretation of 
such behavior lies in the different degrees of protonation of 
amines at different pH values and in the interaction of proto-
nated amines with certain anions. Despite the fact that these 
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Figure S2 Nitrogen adsorption–desorption isotherms for (A) MCM-41 mesoporous material, (B) nanodevice loaded with fluorescein (S1-FL). Inset: pore size distribution 
of the McM-41 mesoporous material and of s1-Fl solid.
Abbreviations: McM-41, mobil composition of matter-41; Vol
abs
, volume of nitrogen absorption; STP, standard temperature and pressure.
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Figure S3 Kinetic release of fluorescein (FL) from solid nanodevice loaded with FL 
(S1-FL) at pH 3.7 and pH 5.5.
Table S2 Content (α) in mmol of 3-[2-(2-aminoethylamino)
ethylamino]propyltrimethoxysilane (N3) and dye per gram of 
siO2 for nanodevice loaded with fluorescein (S1-FL)
Solid αN3 αFL
s1-Fl 0.549 0.376
pKa (acid dissociation logarithmic constant) values can be 
modified when a number of polyamines are anchored onto 
the silica surface, it is clear that at pH 3.7, amines become 
more protonated than at pH 5.5. It has been reported that 
when protonated, tethered open-chain polyamines tend to 
adopt a rigid-like conformation that pushes them toward the 
pore openings.1 This results in a pore blockage that partially 
inhibits the dye release. A second effect is related to the 
interaction of protonated amines with anions (in our case, 
sulfate). This is based on the capacity that polyamines have 
to coordinate anionic species. Polyamines have thus been 
extensively explored as a suitable group for designing abi-
otic ligands for inorganic and biologically important anionic 
guests. Amine-containing receptors are polycations (polyam-
monium ligands), especially at an acidic pH, and they bind 
anionic species via hydrogen bonding and Coulomb forces. 
At pH 5.5 and pH 3.7, a combination of both ammonium and 
amine groups anchored onto the S1-FL surface is expected to 
occur, where the percentage of ammonium groups grows as 
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Figure S4 Schematic representation of the hybrid system nanodevice loaded with 
fluorescein (S1-FL) performance.
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Figure S5 Nanodevice loaded with fluorescein (S1-FL) internalization and 
cell viability assays. Fluorescence microscopy images corresponding to the 
Saccharomyces cerevisiae cells treated with 5 mg/mL of solids (A) MCM-41 and (B) 
S1-FL and incubated at 40°C for 6 hours. The cellular internalization of solid S1-FL 
was followed by fluorescein-associated fluorescence (green). For the clonogenic cell 
survival assays (C), S. cerevisiae cells were treated with 5, 2.5, 1.25, and 0.65 mg/mL 
of s1-Fl. Two independent experiments were performed and data are reported as 
mean ± standard error of the mean.
Abbreviation: MCM-41, mobil composition of matter-41.
of positively charged ammonium groups at pH 3.7, which 
results in a larger electrostatic interaction with sulfate anions. 
Nevertheless, hydrogen-bonding interactions between the 
amine/ammonium groups and sulfate cannot be ruled out, as 
SO
4
2- can act as a hydrogen bond acceptor, whereas amines/
ammonium groups can behave as hydrogen bond donors.2
Yeast uptake of S1-FL
We next tested the applicability of mesoporous nanoparticle 
(MSN) supports based on MCM-41 as nanocarriers for intra-
cellular release in Saccharomyces cerevisiae. Our hypothesis 
was based on the fact that the designed nanoparticle presents 
zero release of the cargo molecule in acidic environments 
(at a pH of around 3–4) in the presence of sulfate, in which 
yeasts are able to grow. Having internalized the solid, the 
lower acidity inside S. cerevisiae (pH 5.5), where the nano-
particles will be located, allows the entrapped molecule to 
be released (see Figure S4).
The conditions for nanoparticle internalization in yeast 
cells were then optimized. We first focused on determining 
the optimal incubation temperature of S. cerevisiae cells with 
nanoparticles and the different agitation rates of cultures. 
Three different temperatures were tested: 30°C, 37°C, and 
40°C. Consequently, 40°C proved the most efficient tempera-
ture for nanoparticle uptake, probably due to the increased 
plasmatic membrane permeability at higher temperatures. 
Then, internalization and cell viability assays were carried 
out with S1-FL at 40°C (see Figure S5). When different 
agitation rates were chosen, no agitation proved optimal for 
the cellular uptake of solids.
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pH lowers. For the correct interpretation of the interaction of 
sulfate with the anchored polyamines, it is important to note 
that sulfate shows a logarithm for its first protonation of 1.9, 
indicating that at pH 3.7 and pH 5.5, sulfate acts like SO
4
2– 
species. The observed behavior (ie, sulfate is able to close 
the gate at pH 3.7 but is unable to inhibit dye release at pH 
5.5) can be explained, bearing in mind the larger proportion 
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